William Court

2.6k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

William Court is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, William Court has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in William Court's work include Protein Kinase Regulation and GTPase Signaling (5 papers), HER2/EGFR in Cancer Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). William Court is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), HER2/EGFR in Cancer Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). William Court collaborates with scholars based in United Kingdom, Spain and Thailand. William Court's co-authors include Suzanne A. Eccles, Frances Boxall, C. Lomas, Miriam Zimmermann, Maria Vinci, Lisa Patterson, Sharon Gowan, Marta Mendiola, David Hardisson and Pornchai O‐charoenrat and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Cell Biology and Cancer Research.

In The Last Decade

William Court

20 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation

2012 783 citations Maria Vinci, Sharon Gowan et al. BMC Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Court United Kingdom	16	978	940	490	480	243	20	2.0k
Tracy Vargo-Gogola United States	21	914 0.9×	995 1.1×	400 0.8×	537 1.1×	181 0.7×	28	2.1k
Sylvie Roberge United States	18	578 0.6×	1.1k 1.2×	654 1.3×	488 1.0×	192 0.8×	39	2.5k
Genee Y. Lee United States	7	1.1k 1.1×	940 1.0×	762 1.6×	322 0.7×	469 1.9×	9	2.2k
William C. Hines United States	17	927 0.9×	920 1.0×	319 0.7×	495 1.0×	442 1.8×	29	2.0k
Anthony R. Howlett United States	21	1.0k 1.0×	1.3k 1.4×	419 0.9×	369 0.8×	521 2.1×	34	2.5k
Siqing Shan United States	17	347 0.4×	893 0.9×	354 0.7×	469 1.0×	135 0.6×	25	1.7k
Nathaniel D. Kirkpatrick United States	19	593 0.6×	972 1.0×	454 0.9×	622 1.3×	160 0.7×	27	2.2k
Kevin J. Metcalf United States	11	610 0.6×	680 0.7×	378 0.8×	315 0.7×	350 1.4×	16	1.7k
Markus Münz Germany	12	1.0k 1.1×	1.0k 1.1×	173 0.4×	372 0.8×	173 0.7×	18	1.9k
Verónica Estrella United States	17	462 0.5×	1.4k 1.5×	449 0.9×	679 1.4×	369 1.5×	28	2.5k

Countries citing papers authored by William Court

Since Specialization

Citations

This map shows the geographic impact of William Court's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Court with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Court more than expected).

Fields of papers citing papers by William Court

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Court. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Court. The network helps show where William Court may publish in the future.

Co-authorship network of co-authors of William Court

This figure shows the co-authorship network connecting the top 25 collaborators of William Court. A scholar is included among the top collaborators of William Court based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Court. William Court is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burmi, Rajpal S., Gary Box, Umar Wazir, et al.. (2022). Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro. Genes. 13(3). 402–402. 4 indexed citations

Brandon, Alexis de Haven, Gary Box, Albert Hallsworth, et al.. (2020). Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice. Scientific Reports. 10(1). 10799–10799. 17 indexed citations

Eccles, Suzanne A., William Court, & Lisa Patterson. (2016). In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis. Methods in molecular biology. 1430. 121–147. 11 indexed citations

Dart, Anna, Gary Box, William Court, et al.. (2015). PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. The Journal of Cell Biology. 211(4). 863–879. 60 indexed citations

Miranda, Elena, Francesco Cuda, William Court, et al.. (2013). A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells. Journal of the American Chemical Society. 135(28). 10418–10425. 151 indexed citations

Vinci, Maria, Sharon Gowan, Frances Boxall, et al.. (2012). Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 10(1). 29–29. 783 indexed citations breakdown →

Reynisson, Jóhannes, William Court, James E. H. Day, et al.. (2009). The identification of novel PLC-γ inhibitors using virtual high throughput screening. Bioorganic & Medicinal Chemistry. 17(8). 3169–3176. 49 indexed citations

Harvey, Amanda, Caroline J. Pennington, Sarah Porter, et al.. (2009). Brk Protects Breast Cancer Cells from Autophagic Cell Death Induced by Loss of Anchorage. American Journal Of Pathology. 175(3). 1226–1234. 46 indexed citations

Box, Carol, Lisa Patterson, William Court, et al.. (2007). Syk Tyrosine Kinase Is Linked to Cell Motility and Progression in Squamous Cell Carcinomas of the Head and Neck. Cancer Research. 67(16). 7907–7916. 65 indexed citations

10.

Court, William, et al.. (2006). Role of the Brk tyrosine kinase in breast cancer progression. Breast Cancer Research. 8(S2). 1 indexed citations

11.

Eccles, Suzanne A., Carol Box, & William Court. (2005). Cell migration/invasion assays and their application in cancer drug discovery. PubMed. 11. 391–421. 93 indexed citations

12.

O‐charoenrat, Pornchai, Helmout Modjtahedi, P. Rhys‐Evans, et al.. (2000). Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.. PubMed. 60(4). 1121–8. 128 indexed citations

13.

O‐charoenrat, Pornchai, Peter Rhŷs‐Evans, Helmout Modjtahedi, et al.. (2000). Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression andin vitro invasion. International Journal of Cancer. 86(3). 307–317. 105 indexed citations

14.

O‐charoenrat, Pornchai, Peter Rhŷs‐Evans, William Court, Gary Box, & Suzanne A. Eccles. (1999). Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands. Clinical & Experimental Metastasis. 17(7). 631–639. 61 indexed citations

15.

Eccles, S. A., G. Box, William Court, et al.. (1996). Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).. PubMed. 56(12). 2815–22. 155 indexed citations

16.

Modjtahedi, Helmout, et al.. (1995). Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.. PubMed. 14(1-6). 337–48. 42 indexed citations

17.

Eccles, Sue, et al.. (1994). Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.. PubMed. 54(19). 5171–7. 56 indexed citations

18.

Eccles, S. A., G. Box, William Court, J Sandle, & Christopher Dean. (1994). Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophysics. 24-25(1-3). 279–291. 25 indexed citations

19.

Eccles, S. A., G. Box, William Court, Mary Collins, & Christopher Dean. (1993). Monoclonal antibodies for the treatment of metastases. Cell Biophysics. 22(1-3). 165–187. 2 indexed citations

20.

Maimets, Toivo, Peter M. Chumakov, Ruth Brain, et al.. (1990). p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.. PubMed. 5(6). 795–81. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact